How to detect the usability of a peptide sequence?

Assessing the availability of peptides typically involves evaluating their biological properties, stability, purity, and functionality:

1. Purity Assessment:

• High-Performance Liquid Chromatography (HPLC): Used to detect the purity of peptides, i.e., the percentage of the target peptide in the sample.
• Mass Spectrometry (MS): Used to determine the molecular mass of peptides, further confirming their purity and structure.

2. Bioactivity Assessment:

• In vitro assays: Such as enzyme inhibition assays and receptor binding studies, to evaluate the biological function of peptides.
• Cellular assays: Testing the effects of peptides in cell models, such as cell proliferation and cytotoxicity.

3. Toxicity and Immunogenicity:

Conduct cytotoxicity tests and immune response evaluations to determine the safety of peptides for biological systems.

4. Stability Testing:

• Thermal stability: Detecting peptide stability at different temperatures through heating experiments.
• pH stability: Testing peptide stability under different pH conditions.

Depending on the intended use and targets of the peptides, these testing methods may vary. Experimental design should be adjusted according to specific circumstances.

BiotechPack, A Biopharmaceutical Characterization and Multi-Omics Mass Spectrometry (MS) Services Provider

Related Services:

Peptide Sequencing

De Novo Peptide Sequencing

Protein Sequencing

Antibody Sequencing

Protein N/C-terminal Sequencing

Full Protein Sequence Determination

Secondary Mass Spectrometry Peptide Sequencing